Zusammenfassung
Die akute Herzinsuffizienz ist das plötzliche Auftreten von Symptomen einer Herzinsuffizienz bzw. deren Verschlechterung, die einer notfallmäßigen Therapie bedürfen. Zu den Symptomen gehören Ruhe- oder Belastungsdyspnoe, Volumenüberladung (pulmonalvenöse Stauung, periphere Ödeme), körperliche Erschöpfung, funktionelle oder strukturelle Störung des Herzens in Ruhe. Klinische Zeichen der Herzinsuffizienz sind Rasselgeräusche beim Lungenödem, das Auftreten eines 3. oder 4. Herztones, gefolgt von Jugularvenenstauung, Leberstauung, positivem hepatojugulären Reflux und peripheren Ödemen. Ein 12-Kanal-EKG gehört zur Basisdiagnostik, daneben sind klinische Untersuchung (Rasselgeräusche oder S3-Galopp), Echokardiographie, Röntgen-Thorax und Labor von Bedeutung. Je nach Symptomatik und Therapie benötigen die Patienten eine nicht invasive, invasive und/oder hämodynamische Überwachung. Die Behandlung beruht im Wesentlichen auf der ursachen- (koronare Reperfusion beim akuten Myokardinfarkt) und symptomorientierten Therapie. Die symptomorientierte Therapie besteht aus Sauerstoffgabe, Analgosedierung und hämodynamischer Stabilisierung (Diuretika, Vasodilatatoren, positiv inotrope Substanzen, Vasopressoren, mechanische Kreislaufunterstützungssysteme).
Literatur
Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J (2005) In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 46:57–64
Binanay C, Califf RM, Hasselblad V, O'Connor CM, Shah MR, Sopko G, Stevenson LW, Francis GS, Leier CV, Miller LW (2005) Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA 294:1625–1633
Böhm M, Link A, Cai D, Nieminen MS, Filippatos GS, Salem R, Cohen Solal A, Huang B, Padley RJ, Kivikko M et al (2011) Beneficial association of beta-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients with Acute Heart Failure in Need of Intravenous Inotropic Support trial. Crit Care Med 39:940–944
Cleland JG, Freemantle N, Coletta AP, Clark AL (2006) Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE. Eur J Heart Fail 8:105–110
Cleland JG, Swedberg K, Cohen-Solal A, Cosin-Aguilar J, Dietz R, Follath F, Gavazzi A, Hobbs R, Korewicki J, Madeira HC et al (2000) The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2:123–132
Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW et al (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388–2442
Felker GM, Benza RL, Chandler AB, Leimberger JD, Cuffe MS, Califf RM, Gheorghiade M, O'Connor CM (2003) Heart failure etiology and response to milrinone in decompensated heart failure: results from the OPTIME-CHF study. J Am Coll Cardiol 41:997–1003
Gheorghiade M, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, She L, Stough WG, Yancy CW, Young JB, Fonarow GC (2006) Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 296:2217–2226
Hamm CW, Bassand JP, Agewall S, Bax J, Boersma E, Bueno H, Caso P, Dudek D, Gielen S, Huber K et al (2011) ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 32:2999–3054
Howlett JG (2011) Acute heart failure: lessons learned so far. Can J Cardiol 27:284–295
Link A, Böhm M (2009) ESC Leitlinien 2008 - Leitlinien zur akuten Herzinsuffizienz. Intensivmedizin 46:377–382
Majure DT, Teerlink JR (2011) Update on the management of acute decompensated heart failure. Curr Treat Options Cardiovasc Med 13:570–585
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847
McMurray JJ, Stewart S (2000) Epidemiology, aetiology, and prognosis of heart failure. Heart 83:596–602
Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Poder P, Kivikko M (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized trial. JAMA 297:1883–1891
Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725–2736
O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ et al (2011) Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 365:32–43
Sayer GT, Baker JN, Parks KA (2012) Heart rescue: the role of mechanical circulatory support in the management of severe refractory cardiogenic shock. Curr Opin Crit Care 18:409–416
Shah MR, Hasselblad V, Stevenson LW, Binanay C, O'Connor CM, Sopko G, Califf RM (2005) Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294:1664–1670
Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569–2619
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this entry
Cite this entry
Link, A., Böhm, M. (2014). Akute Herzinsuffizienz. In: Lehnert, H., et al. SpringerReference Innere Medizin. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54676-1_176-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-54676-1_176-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-54676-1
eBook Packages: Springer Referenz Medizin